The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases

Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring

(2019) Carine A. Halaby et al.   GENETICS IN MEDICINE

Research priorities for liver glycogen storage disease: An international priority setting partnership with the James Lind Alliance

(2019) Fabian Peeks et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Inborn Errors of Metabolism with Hypoglycemia

(2018) David A. Weinstein et al.   PEDIATRIC CLINICS OF NORTH AMERICA

Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome

(2016) Christiaan P. Sentner et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Assessing disease severity in Pompe disease: The roles of a urinary glucose tetrasaccharide biomarker and imaging techniques

(2012) Sarah P. Young et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS

Rapid Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry Assay for a Characteristic Glycogen-Derived Tetrasaccharide in Pompe Disease and Other Glycogen Storage Diseases

(2012) W. Sluiter et al.   CLINICAL CHEMISTRY

Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker

(2009) Sarah P Young et al.   GENETICS IN MEDICINE